Biography and academic profile
Dr. Selvakumar Elangovan is a cancer biologist with over 18 years of experience in cancer cell signaling, tumor suppression, and cancer stem cell biology. His research focuses on breast cancer and leukemia, examining epithelial-mesenchymal transition, epigenetic regulation, and mechanisms of chemoresistance and metastasis. He completed postdoctoral training at New York Medical College and Augusta University, USA, contributing to the understanding of tumor suppressor genes and metabolite transporters (SLC5A8, SLC6A14, GPR109A) in mammary tumorigenesis. His work on the SIRT1–ER α axis, DNMT1-driven cancer stem cell maintenance, and estrogen-related receptor alpha (ERRα) in breast cancer stemness and chemoresistance is widely recognized. His research is supported by SERB, DST, and ICMR.



